Connect with us

TRENDING

Medical Marijuana Inc (OTCMKTS:MJNA)’s Subsidiary – HempMeds Allows Customers To Buy CBD Products Now And Pay Later In EMIs

Published

on

Medical Marijuana Inc (OTCMKTS:MJNA)’s Subsidiary – HempMeds entered a pact with Sezzle to offer alternative payment solutions to its customers. According to the deal, the alternative digital payment platform – Sezzle allows customers to buy items from HempMeds with a 25% down payment and pay the balance amount in three installments. It is a boon for customers on a budget. They can make the balance payment every two weeks (total 3 EMIs) after initial down payment.

Three EMIs for customers on a budget

Todd Morrow, President of HempMeds, said the customers find it difficult to pay for the items purchased online during the festive season. To help the customers purchase their favorite items from HempMeds, Sezzle offered an alternative payment solution and assumes the risk for the balance amount. He further said the company intends to improve the shopping experience for the customers and ease the financial difficulties.

First to introduce hemp-based CBD oil products

HempMeds is the first company to offer hemp-derived CBD products in bulk quantity for customers in the US. It also gets the credit to obtain important approvals for cannabidiol products from the federal governments in Paraguay, Mexico, Brazil, and Argentina. HempMeds is the first company to get its products certified by Hemp Authority in the US. Prescriber’s Digital Reference has listed the products of HempMeds.

Online search volume for CBD surges

Dr. Stuart Titus, Chief Executive Officer of Medical Marijuana, said online search volume for CBD products has surged by 117.7% this year when compared to the previous year. Alliance with Sezzle will improve customers searching online to purchase CBD products. As a result, more people will get access to its CBD products.

Operational and financial highlights

Medical Marijuana has reported revenues of $17.7 million in Q3 2019. HempMeds has introduced the new CBD products for pets. Medical Marijuana’s subsidiary – Kannaway received the membership in the Industrial Hemp Association of Europe. Both Kannaway and Medical Marijuana have received two Stevie Award International Business Awards. To develop and market CBD DNA test products, Kannaway entered a pact with Endocanna Health.

Stuart said Medical Marijuana, along with its subsidiaries, is pleased to continue the operations in the hemp-derived CBD industry. He said the company is encouraged with favorable regulatory developments and the flourishing CBD market worldwide.

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.